Evonik is
one of the world's leading specialty chemicals companies. Profitable
growth and a sustained increase in the value of the company form the
heart of our strategy, which is supported by our owners, RAG-Stiftung
(74.99 percent) and funds managed by CVC Capital Partners (25.01
percent). Our specialty chemicals activities focus on high-growth
megatrends—especially health, nutrition, resource efficiency, and
globalization—and our goal is to enter attractive future-oriented
markets.
In 2011 Evonik’s roughly 33,000 employees generated sales of €14.5 billion and an operating result (EBITDA) of €2.8 billion. More than 70 percent of sales are generated outside Germany, providing convincing evidence that our business is global.
In 2011 Evonik’s roughly 33,000 employees generated sales of €14.5 billion and an operating result (EBITDA) of €2.8 billion. More than 70 percent of sales are generated outside Germany, providing convincing evidence that our business is global.
Visit the website HERE.
The Global Miller
This blog is maintained by The Global Miller staff and is supported by the magazine GFMT
which is published by Perendale Publishers Limited.
For additional daily news from milling around the world: global-milling.com
No comments:
Post a Comment